Replies to post #442628 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Show us the record of any human clinical trial in MS with A2-73.

All the examples are written in present tense. E.g. "A 27 year-old female presents with relapsing-remitting multiple sclerosis. She begins...." etc.

[kevindenver]

This publication may be of interest on this topic. Murine and preclinical data has been collected.

https://www.anavex.com/press-releases/anavex-life-sciences-announces-publication-of-foundational-data-for-anavex%C2%AE2-73-(blarcamesine)-in-multiple-sclerosis-(ms)

I should also note on the indication of MS, Biogen knows of the potential too. As there was a past material transfer agreement to investigate Blarcamesine with them.